.png)

Before using Series B capital to enter a new market segment, a company should prove that its core business has durable retention, strong margins, and sustained growth. It should also show early customers in the new segment, separate unit economics, and a go-to-market plan built for the new buyer.
According to ICONIQ Growth's research on growth-stage SaaS companies, Series B expansion rounds are funded when core-market unit economics are stable and the base business has demonstrated retention durability before the raise launches. Growth equity analysts evaluate the base business first. If the unit economics there are clean, the expansion argument gets a hearing. If they show strain, the new segment thesis gives analysts a structural reason to reallocate capital to a safer deployment.
Founders preparing for Series B who plan to use the raise to enter an adjacent vertical, an upmarket tier, or a new geography face a sequencing problem. The expansion story is compelling. The metrics required to tell it credibly are harder to build. Understanding exactly what analysts need to see, and in what order, is how founders protect the valuation multiple before the first diligence call.
The Capital Raise Pre-Flight is IRC Partners' fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership.
Growth equity analysts separate the expansion thesis from the core-market evidence. The thesis gets evaluated on its own logic. The core-market evidence gets evaluated on its own numbers. Founders who conflate the two, presenting expansion projections before core metrics are clean, give analysts a structural reason to discount the entire model.
Three metrics carry the most weight in this evaluation.
According to ICONIQ Growth benchmarks for B2B SaaS companies at the Series B stage, top-quartile companies show net revenue retention above 120%. Median performance sits between 105% and 115%. Analysts treat NRR as the single most reliable indicator of product-market fit durability in the core segment. A company with NRR below 100% entering a new segment is signaling that the core segment has unresolved churn before the expansion spend begins.
According to KeyBanc Capital Markets' annual SaaS survey, B2B SaaS companies at Series B targeting institutional growth equity should show gross margins of at least 70%. Companies below that threshold face two simultaneous questions in diligence: whether the core business can fund its own growth, and whether the new segment will carry similar or worse margin structure. Analysts price both risks into the multiple.
OpenView Partners' SaaS benchmarks indicate that B2B SaaS companies at $10M to $30M ARR should show year-over-year revenue growth of at least 80% to 100% to support a growth equity expansion narrative. Companies growing below 60% year-over-year face a harder argument, because the expansion thesis requires investors to believe the new segment will accelerate a trajectory that the core segment has already begun to slow.
Key threshold: According to ICONIQ Growth, Series B companies that show NRR above 105%, gross margin above 70%, and year-over-year growth above 80% enter the investment committee evaluation with core-market evidence that supports the expansion thesis.
Demonstrating that the core business is healthy is the first gate. The second is demonstrating that the new segment has been tested, even at small scale, before the capital raise closes.
Expansion capital funds a hypothesis. Core-market capital funds a motion that has already been proven in the field. Analysts price those two deployment types differently, and the evidence package for a new segment entry has to close that gap before the raise closes. Founders who reduce that hypothesis risk with evidence before the raise closes give analysts a reason to underwrite the expansion at a higher confidence level.
The evidence package for a new segment entry argument typically requires three components.
According to ICONIQ Growth's guidance on expansion-stage SaaS, analysts expect founders to show at least two to four closed customers in the target segment before the raise closes. The purpose is to confirm that the ICP in the new segment responds to the same sales motion and pricing model as the core segment. Without pilot data, the expansion thesis remains a market-sizing argument, and analysts price the hypothesis risk into the deal at full weight.
Founders raising Series B while still in the early stages of building institutional investor readiness should treat pilot segment revenue as a pre-raise requirement and complete that work before going to market.
Analysts will model the new segment separately from the core business. According to KeyBanc Capital Markets' SaaS survey data, the most common diligence failure in expansion-stage raises is a founder presenting blended unit economics that mask segment-level deterioration. If the new segment carries a longer sales cycle, a lower ACV, or a higher CAC than the core segment, those differences need to appear in the model before diligence surfaces them.
Presenting clean segment-level separation signals operational maturity. It tells analysts that the founder has already stress-tested the economics of the new segment, and that the expansion capital has a defined deployment plan with measurable return assumptions.
According to OpenView Partners' product-led and sales-led growth research, the go-to-market motion for an adjacent segment often requires a different sales profile, a different buyer persona, or a different channel. Analysts evaluate whether the founder has identified those differences and built a hiring and channel plan that reflects them.
A segment entry plan that assumes the existing sales team will cover the new segment without modification is a flag. It suggests the founder has sized the opportunity without modeling the cost of capturing it.
The sequencing principle: Core metrics must be stable. Pilot revenue must be confirmed. Segment economics must be modeled separately. The go-to-market motion must be designed for the new buyer. That is the order analysts expect to see the evidence presented.
The structure of the diligence package matters as much as the content. Analysts read packages in a specific order, and the expansion thesis lands differently depending on where it appears.
The first section of any Series B diligence package should establish core-market health. According to ICONIQ Growth's framework for growth equity diligence, analysts form their initial risk view early in the materials review. If the first data they encounter shows strong NRR, improving CAC payback, and consistent gross margin, the expansion thesis gets read through a favorable lens.
If the package leads with the expansion opportunity and buries the core metrics, analysts arrive at the unit economics section already skeptical. The order creates a credibility problem that the numbers alone cannot solve.
Analysts need to see a clear separation between the capital required to maintain core-market momentum and the capital allocated to segment entry. According to Bessemer Venture Partners' guidance on Series B capital allocation, blended use-of-funds slides are a diligence flag. They suggest the founder has sized the raise without stress-testing which initiatives would be cut if the expansion segment underperforms in the first two quarters post-close.
A clean capital allocation model shows: core-market growth budget, segment entry budget, and the assumptions behind each. It also shows what the business looks like if the new segment ramps more slowly than projected.
{{main-cta}}
The expansion argument is most credible when presented as a progression from observation to pilot to evidence. Analysts evaluating cap table structure and governance before Series B apply the same progression logic to segment entry: they want to see that the founder identified the opportunity, tested it at small scale, and is now asking for capital to scale a motion that has already shown early proof.
The structure to follow:
According to OpenView Partners' expansion research, founders who include a documented risk case in the expansion section of their diligence package reduce the time analysts spend stress-testing the model independently. Presenting the risk case first signals that the founder has already done that work.
Founders who want a structured view of where their diligence package stands before going to market should review the institutional ownership standards that analysts apply at Series B alongside the segment readiness criteria in this article.
According to ICONIQ Growth benchmarks, B2B SaaS companies between $10M and $30M ARR are the primary target for Series B expansion capital. ARR alone does not determine whether the expansion thesis receives credit. Analysts evaluate the growth rate, NRR, and CAC payback of the existing ARR base before assessing whether the expansion capital is defensible.
According to ICONIQ Growth, top-quartile Series B SaaS companies show NRR above 120%. Median performance runs between 105% and 115%. Analysts treat NRR below 100% as a signal that the core segment has unresolved retention issues, which makes expansion capital harder to justify in the investment committee.
According to ICONIQ Growth's guidance on expansion-stage SaaS, analysts expect to see at least two to four closed customers in the target segment before the raise closes. The goal is to confirm that the new segment ICP responds to the same sales motion and pricing model as the core segment. Market-sizing data without closed pilot customers carries less analytical weight in the investment committee evaluation.
According to KeyBanc Capital Markets' annual SaaS survey, B2B SaaS companies at Series B should show gross margins of at least 70% before pursuing institutional growth equity. Companies below that floor face diligence questions about whether the core business can fund its own growth and whether the new segment will compound the margin pressure.
According to Bessemer Venture Partners' guidance on Series B capital allocation, blended use-of-funds slides signal that the founder has sized the raise without separating core-market maintenance capital from segment entry capital. Analysts need to model each use case independently to stress-test what happens if the new segment underperforms in the first two quarters post-close.
According to OpenView Partners' SaaS benchmarks, B2B SaaS companies at $10M to $30M ARR should show year-over-year revenue growth of at least 80% to 100% to support a growth equity expansion narrative. Companies growing below 60% year-over-year face a harder argument because the expansion thesis asks investors to bet on acceleration from a base that is already decelerating.
According to OpenView Partners' expansion research, founders who include a documented risk case in the expansion section of their diligence package reduce the time analysts spend stress-testing the model independently. The risk case should show what the business looks like if the new segment ramps at half the projected base case pace. Presenting the downside proactively signals analytical discipline and increases analyst confidence in the upside projections.
The Capital Raise Pre-Flight is IRC Partners’ fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership. It is where every engagement begins, whether you are pre-revenue building toward a first institutional round or scaling a company that has raised before. For deals that clear, the full strategic partnership follows. IRC Partners advises operators raising $5M to $250M of institutional capital. If you are taking a raise to market, start here.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of seven
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.